LabCorp's $85M Orchid Deal Depends On Divestment: FTC
The Federal Trade Commission has asked Laboratory Corp. of America Holdings to divest a part of Orchid Cellmark Inc.'s paternity testing business in order to have its $85 million purchase of...To view the full article, register now.
Already a subscriber? Click here to view full article